NASDAQ:CATB
Delisted

Catabasis Pharmaceuticals Stock Price (Quote)

$3.36
+0.195 (+6.16%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $3.02 $6.17 Friday, 27th May 2022 CATB stock ended at $3.36. This is 6.16% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 6.65% from a day low at $3.16 to a day high of $3.37.
90 days $3.02 $7.25
52 weeks $1.20 $10.26

Historical Catabasis Pharmaceuticals prices

Date Open High Low Close Volume
2021-07-08 $1.94 $2.05 $1.88 $2.02 725 559
2021-07-07 $2.04 $2.06 $1.91 $1.98 717 746
2021-07-06 $2.09 $2.11 $2.01 $2.04 286 275
2021-07-02 $2.15 $2.15 $2.04 $2.08 257 716
2021-07-01 $2.08 $2.16 $2.05 $2.15 533 392
2021-06-30 $2.17 $2.19 $2.08 $2.11 453 289
2021-06-29 $2.26 $2.29 $2.13 $2.16 564 235
2021-06-28 $2.29 $2.34 $2.21 $2.26 799 638
2021-06-25 $2.15 $2.26 $2.08 $2.15 3 640 666
2021-06-24 $1.98 $2.24 $1.98 $2.15 1 527 720
2021-06-23 $1.94 $2.00 $1.92 $1.99 541 669
2021-06-22 $1.98 $1.99 $1.90 $1.94 716 153
2021-06-21 $2.08 $2.08 $1.92 $2.00 1 292 918
2021-06-18 $2.18 $2.20 $2.06 $2.10 1 229 968
2021-06-17 $2.07 $2.41 $2.04 $2.22 6 299 949
2021-06-16 $2.39 $2.62 $2.11 $2.21 23 773 369
2021-06-15 $2.14 $2.15 $2.00 $2.04 205 694
2021-06-14 $2.12 $2.18 $2.10 $2.11 237 431
2021-06-11 $2.19 $2.19 $2.06 $2.07 243 507
2021-06-10 $2.15 $2.22 $2.08 $2.17 281 921
2021-06-09 $2.14 $2.26 $2.11 $2.11 257 547
2021-06-08 $2.16 $2.19 $2.04 $2.16 477 492
2021-06-07 $2.02 $2.15 $1.97 $2.14 482 098
2021-06-04 $2.00 $2.02 $1.93 $2.01 331 967
2021-06-03 $2.07 $2.07 $1.96 $2.02 273 585
Click to get the best stock tips daily for free!

About Catabasis Pharmaceuticals

Catabasis Pharmaceuticals Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. Its product pipeline includes CAT-1004, an oral small molecule that has completed Phase 1 clinical trials for the treatment of duchenne muscular dystrophy (DMD); CAT-2054, which is in Phase I clinical trial for the treatment of hypercholesterolemia i... CATB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT